Related references
Note: Only part of the references are listed.Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect?
David A. Forero-Pena et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
Diego Macias Saint-Gerons et al.
MALARIA JOURNAL (2022)
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors
Gil Awada et al.
MELANOMA RESEARCH (2022)
Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19
Marine Ambar Akkaoui et al.
BIOLOGICAL PSYCHIATRY (2021)
A case report of hydroxychloroquine-induced auditory and visual hallucination
Zakiye Ganjei et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2021)
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
Jennifer C. E. Lane et al.
RHEUMATOLOGY (2021)
Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study
Andreas Neumayr et al.
CLINICAL INFECTIOUS DISEASES (2021)
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
Alessandra Costanza et al.
BEHAVIORAL SCIENCES (2021)
Psychotic Agitation in a Patient with COVID-19: Pathogenesis or latrogenesis?
Umit Haluk Yesilkaya et al.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY (2021)
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease
G. A. Horne et al.
LEUKEMIA (2020)
Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
Kenichiro Sato et al.
BIOSCIENCE TRENDS (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern
Bada Sharanappa Nagaraja et al.
JOURNAL OF PUBLIC HEALTH (2020)
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
Philippe Garcia et al.
DRUG SAFETY (2020)
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients
Eline L. Giraud et al.
EXPERT OPINION ON DRUG SAFETY (2020)
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Magnus Nakrem Lyngbakken et al.
NATURE COMMUNICATIONS (2020)
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
Robert J. Ulrich et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
Cheng-Pin Chen et al.
PLOS ONE (2020)
Psychiatric side effects of chloroquine in COVID-19 patients: two case reports
Roukaya Benjelloun et al.
PAN AFRICAN MEDICAL JOURNAL (2020)
Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial
Lydia T. de Moraes Falcao et al.
JGH OPEN (2020)
Psychosis consequent to antimalarial drug use in a young child
Jitender Aneja et al.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease
M. Iudici et al.
LUPUS (2018)
Associations between Use of Antimalarial Medications and Health among US Veterans of the Wars in Iraq and Afghanistan
Aaron I. Schneiderman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study
Lavanya Mittal et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article
Annamaria Mascolo et al.
INFLAMMOPHARMACOLOGY (2018)
Patients with preexisting psychiatric disorders admitted to ICU: a descriptive and retrospective cohort study
Arnaud Gacouin et al.
ANNALS OF INTENSIVE CARE (2017)
Psychiatric adverse effects of chloroquine
Anna Bogaczewicz et al.
PSYCHIATRIA I PSYCHOLOGIA KLINICZNA-JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY (2017)
Acute psychosis presenting in a patient with systemic lupus erythematosus: Questions
Sheena Sharma et al.
PEDIATRIC NEPHROLOGY (2016)
Chloroquine-associated psychosis mimicking very late-onset schizophrenia: Case Report
Yong Tae Kwak et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2015)
Psychiatric symptoms induced by hydroxychloroquine
J. A. Gonzalez-Nieto et al.
LUPUS (2015)
Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy
Nicole M. Maxwell et al.
CLINICAL CASE REPORTS (2015)
Hydroxychloraquine-Induced Acute Psychotic Disorder in a Female Patient with Rheumatoid Arthritis: a Case Report
Ebru Altintas
DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES (2015)
Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India
Partha Sarathi Biswas et al.
GENERAL HOSPITAL PSYCHIATRY (2014)
Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus-a case report
J. Bogaczewicz et al.
LUPUS (2014)
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
Issaka Sagara et al.
MALARIA JOURNAL (2014)
Two Challenge and Rechallenge Episodes of Chloroquine-Induced Psychotic Mania in a Patient with Rheumatoid Arthritis
B. K. Plesnicar et al.
AKTUELLE RHEUMATOLOGIE (2013)
Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs
Natalia Pinho de Oliveira Ribeiro et al.
COMPREHENSIVE PSYCHIATRY (2013)
Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders
Cornelia Schneider et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female
WenYu Hsu et al.
ACTA NEUROPSYCHIATRICA (2011)
Similar Efficacy and Tolerability of Double-Dose Chloroquine and Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in Guinea-Bissau: A Randomized Trial
Johan Ursing et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Suicide by Skull Stab Wounds A Case of Drug-Induced Psychosis
Nathalie Jousset et al.
AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY (2010)
Evaluation of Mood Profiles During Malaria Chemoprophylaxis: A Randomized, Double-Blind, Four-Arm Study
Patricia Schlagenhauf et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Chloroquine psychosis masquerading as PCP: A case report
Gregory B. Collins et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2008)
Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers
Christine Korhonen et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2007)
Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria
C Franco-Paredes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection
DS Telgt et al.
ANNALS OF PHARMACOTHERAPY (2005)
Hallucinations during treatment with hydrochloroquine
V Ferraro et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2004)
The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials
CR Meier et al.
DRUG SAFETY (2004)
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
P Schlagenhauf et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
